首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1517522

體外診斷 (IVD)品管：全球市場

In Vitro Diagnostics (IVD) Quality Controls: Global Market

出版日期: 2024年07月12日 | 出版商:

BCC Research | 英文 124 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球體外診斷 (IVD)品管市場規模預計將從 2024 年的 15 億美元增至 2029 年底的21 億美元，預測期內複合年成長率為 7.8%。

免疫診斷產業預計到 2029年終將達到 6,257 億美元，複合年成長率為 8.6%，較 2024 年的 4,142 億美元成長 8.6%。此外，血液學產業預計將從 2024 年的 2.893 億美元成長到 2029 年底的4,351 億美元，複合年成長率為 8.5%。

該報告調查了全球體外診斷（IVD）品管市場，並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測、各種細分和詳細的區域分析。

細分細分
市場區隔：按測試類型
免疫診斷
臨床化學
血液學
分子診斷
微生物學
其他
市場細分：按製造商分類
第三方控制
ODM控制
市場區隔：依產品/服務
品管產品
資料管理解決方案
品質保證服務
市場區隔：按最終用戶
診斷實驗室
醫院/診所
照護現場中心
研究機構
其他
地域分佈
市場區隔：按地區
北美洲
歐洲
亞太地區
其他地區

第6章競爭訊息

公司排名
協議、合作和夥伴關係
IVD 開發和新興企業

第 7 章永續性

ESG 在 IVD 產業的重要性
IVD產業的ESG實踐
環保性能
社會表現
管治績效
案例研究
BCC 的觀點

第8章附錄

調查方法
參考
公司簡介
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MICROBIOLOGICS
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: BIO233B

The global market for In Vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 and is projected to reach $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.

The immunodiagnostics market for In Vitro diagnostics quality controls is expected to grow from $414.2 billion in 2024 and is projected to reach $625.7 billion by the end of 2029, at a CAGR of 8.6% during the forecast period of 2024 to 2029.

The hematology market for In Vitro diagnostics quality controls is expected to grow from $289.3 million in 2024 and is projected to reach $435.1 billion by the end of 2029, at a CAGR of 8.5% during the forecast period of 2024 to 2029.

Report Scope

This report provides details about the market for in vitro diagnostics quality controls used in checking the in vitro diagnostic devices present in labs, clinics and hospitals. This report will also highlight the current and future market potentiality of in vitro diagnostics quality controls, with a detailed analysis of the competitive environment between companies. Drivers, restraints, opportunities, prevalence or incidence of chronic diseases, and a regulatory scenario assessment will be covered in the current report. The report includes market projections for 2029 and market shares for key players.

Based on test type, the market is segmented into immunodiagnostics, clinical chemistry, hematology and hemostasis, molecular diagnostics, microbiology, and others. Based on products and services, the market is categorized into quality control products, data management solutions and quality assurance services. Based on type of manufacturer, the market is segmented into third-party controls and OEM controls. Based on end users, the market is segmented into hospitals, diagnostic laboratories and academic institutions.

By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World. Detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and GCC countries are covered within the regional segments. For market estimates, data will be provided for 2023 as the base year, with estimates for 2024 and forecast value for 2029.

Report Includes

40 data tables and 40 additional tables
An overview of the global market for in vitro diagnostics (IVD) quality controls
Analysis of global market trends, featuring revenue data for 2021-2023, estimated figures for 2024, and projected CAGRs through 2029
Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by test type, manufacturer, product/services, end user and region
Discussion of market drivers and restraints and other dynamics
Assessment of the regulatory landscape, including product recalls
Analysis of the key companies' market shares, recent M&A activity, acquisitions, joint ventures, partnerships, and patents
Company profiles,including Abbott, bioMerieux, F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market and Technology Background

Introduction
Overview
Classification of In Vitro Diagnostics Elements
Importance of In Vitro Diagnostics Quality Control
Regulations
Regulation of IVD products in Different countries

Chapter 3 Market Dynamics

Market Drivers
Rise in the Aging Population and Dependency on Frequent Diagnosis Procedures
Rising Demand for Third-Party Quality Control Products
Rising Incidence of Chronic Disease Cases
Strengthening Clinical Laboratories
Improving the Quality of Point-of-Care Testing
Market Restraints
Challenges for Quality Control Product Packaging
Increases in Shipping Costs or Service Issues
Improper Operation and Maintenance of Laboratory Equipment and Consumables
Market Opportunities
Rise in Home Care Testing Devices
Demand for Point-of-Care (POC) Testing Units

Chapter 4 Emerging Technologies and Developments

Artificial Intelligence
Prioritizing Old IVD Techniques
Automating In-Vitro Diagnostic Devices
Emerging Trends in In Vitro Diagnostics
FDA Approval
Rise in Demand for Personalized Medicine

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown by Test Type
Immunodiagnostics
Clinical Chemistry
Hematology
Molecular Diagnostics
Microbiology
Other Test Types
Market Breakdown by Type of Manufacturer
Third-party Controls
ODM Controls
Market Breakdown by Products and Services
Quality Control Products
Data Management Solutions
Quality Assurance Services
Market Breakdown by End User
Diagnostic Laboratories
Hospitals and Clinics
Point-of-Care Centers
Research Institutions
Other End Users
Geographic Breakdown
Market Analysis by Region
North America
Market Size and Forecast
U.S.
Canada
Mexico
Europe
Market Size and Forecast
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Market Size and Forecast
Japan
China
India
Australia and New Zealand
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast
Brazil
GCC Countries
Rest of the World Countries

Chapter 6 Competitive Intelligence

Introduction
Global Analysis of Company Market Ranking
Agreements, Collaborations and Partnerships
In Vitro Diagnostics Developments and Startups, 2021-2023

Chapter 7 Sustainability

Importance of ESG in the In Vitro Diagnostics Industry
ESG Practices in the In Vitro Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
Case Studies
BCC Research Viewpoint

Chapter 8 Appendix

Research Methodology
References
Company Profiles
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
MICROBIOLOGICS
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table : Global Market for In Vitro Diagnostics Quality Controls, by Test Type, Through 2029
Table 1 : Global Market for In Vitro Diagnostics Quality Controls, by Test Type, Through 2029
Table 2 : Global Market for Immunodiagnostics, by Region, Through 2029
Table 3 : Global Market for Clinical Chemistry, by Region, Through 2029
Table 4 : Global Market for Hematology, by Region, Through 2029
Table 5 : Global Market for Molecular Diagnostics, by Region, Through 2029
Table 6 : Global Market for Microbiology, by Region, Through 2029
Table 7 : Global Market for Other Test Types, by Region, Through 2029
Table 8 : Global Market for In Vitro Diagnostics Quality Controls, by Type of Manufacturer, Through 2029
Table 9 : Global Market for Third-party Controls, by Region, Through 2029
Table 10 : Global Market for ODM Controls, by Region, Through 2029
Table 11 : Global Market for In Vitro Diagnostics Quality Controls, by Type of Product and Service, Through 2029
Table 12 : Global Market for Quality Control Products, by Region, Through 2029
Table 13 : Global Market for Serum/Plasma-Based Controls, by Region, Through 2029
Table 14 : Global Market for Whole Blood-Based Controls, by Region, Through 2029
Table 15 : Global Market for Urine-based Controls, by Region, Through 2029
Table 16 : Global Market for Other Quality Control Products, by Region, Through 2029
Table 17 : Global Market for Data Management Solutions, by Region, Through 2029
Table 18 : Global Market for Quality Assurance Services, by Region, Through 2029
Table 19 : Global Market for In Vitro Diagnostics Quality Controls, by End User, Through 2029
Table 20 : Global Market for IVD Quality Controls in Diagnostic Laboratories, by Region, Through 2029
Table 21 : Global Market for IVD Quality Controls in Hospitals and Clinics, by Region, Through 2029
Table 22 : Global Market for IVD Quality Controls in Point-of-Care Centers, by Region, Through 2029
Table 23 : Global Market for IVD Quality Controls in Research Institutions, by Region, Through 2029
Table 24 : Global Market for Other End Users, by Region, Through 2029
Table 25 : Global Market for In Vitro Diagnostics Quality Controls, by Region, Through 2029
Table 26 : North American Market for In Vitro Diagnostics Quality Controls, by Country, Through 2029
Table 27 : European Market for In Vitro Diagnostics Quality Controls, by Country, Through 2029
Table 28 : Asia-Pacific Market for In Vitro Diagnostics Quality Controls, by Country, Through 2029
Table 29 : Rest of the World Market for In Vitro Diagnostics Quality Controls, by Country/Sub-Region, Through 2029
Table 30 : ESG Practices: Environmental Performance
Table 31 : ESG Practices: Social Performance
Table 32 : ESG Practices: Governance Performance
Table 33 : Abbott: Company Snapshot
Table 34 : Abbott: Financial Performance, FY2022 and 2023
Table 35 : Abbott: Product Portfolio
Table 36 : Abbott: News/Key Developments, 2021 and 2022
Table 37 : BD: Company Snapshot
Table 38 : BD: Financial Performance, FY 2022 and 2023
Table 39 : BD: Product Portfolio
Table 40 : BD: News/Key Developments, 2023 and 2024
Table 41 : bioMerieux: Company Snapshot
Table 42 : bioMerieux: Financial Performance, FY 2022 and 2023
Table 43 : bioMerieux: Product Portfolio
Table 44 : bioMerieux: News/Key Developments, 2023
Table 45 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 46 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 47 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 48 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 49 : Bio-Techne: Company Snapshot
Table 50 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 51 : Bio-Techne: Product Portfolio
Table 52 : Bio-Techne: News/Key Developments, 2022 and 2023
Table 53 : Danaher Corp.: Company Snapshot
Table 54 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 55 : Danaher Corp.: Product Portfolio
Table 56 : Danaher Corp.: News/Key Developments, 2021-2023
Table 57 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 58 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 59 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 60 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 61 : Microbiologics: Company Snapshot
Table 62 : Microbiologics: Product Portfolio
Table 63 : Microbiologics: News/Key Developments, 2022
Table 64 : QuidelOrtho Corp.: Company Snapshot
Table 65 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 66 : QuidelOrtho Corp.: Product Portfolio
Table 67 : QuidelOrtho Corp.: News/Key Developments, 2021-2024
Table 68 : Siemens Healthineers AG: Company Snapshot
Table 69 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 70 : Siemens Healthineers AG: Product Portfolio
Table 71 : Siemens Healthineers AG: News/Key Developments, 2021-2023
Table 72 : Sysmex Corp.: Company Snapshot
Table 73 : Sysmex Corp.: Financial Performance, FY 2021 and 2022
Table 74 : Sysmex Corp.: Product Portfolio
Table 75 : Sysmex Corp.: News/Key Developments, 2022 and 2023
Table 76 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 77 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 78 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 79 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023

List of Figures

Summary Figure : Global Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023
Figure 1 : In Vitro Diagnostics (IVD) Quality Controls Global Market: Market Dynamics
Figure 2 : Elderly Population (Aged 65 and above), by Top Countries, 2022
Figure 3 : Comparison Between Third-Party Controls and Original Equipment Manufacturer Controls
Figure 4 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Test Type 2023
Figure 5 : Global Market Shares of In Vitro Diagnostics Quality Control, by Type of Manufacturer 2023
Figure 6 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Type of Product and Service, 2023
Figure 7 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Type of Quality Control Product, 2023
Figure 8 : Global Market Shares of In Vitro Diagnostics Quality Controls, by End-user, 2023
Figure 9 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Region, 2023
Figure 10 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023
Figure 11 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Type of Manufacturer, 2023
Figure 12 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023
Figure 13 : North American Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023
Figure 14 : North American Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023
Figure 15 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Country, 2023
Figure 16 : European Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023
Figure 17 : European Market Shares of In Vitro Diagnostics Quality Controls, by Type of Manufacturer, 2023
Figure 18 : European Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023
Figure 19 : European Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023
Figure 20 : European Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023
Figure 21 : European Market Shares of In Vitro Diagnostics Quality Controls, by Country, 2023
Figure 22 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023
Figure 23 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Type of Manufacturer, 2023
Figure 24 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023
Figure 25 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023
Figure 26 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023
Figure 27 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Country, 2023
Figure 28 : Rest of World Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023
Figure 29 : Rest of World Market Shares of In Vitro Diagnostic Quality Controls, by Type of Manufacturer, 2023
Figure 30 : Rest of World Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023
Figure 31 : Rest of World Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023
Figure 32 : Rest of World Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023
Figure 33 : Rest of the World Market Shares of In Vitro Diagnostics Quality Controls, by Country/Sub-Region, 2023
Figure 34 : Global Market Ranking of In Vitro Diagnostics Quality Controls, by Company, 2023
Figure 35 : Snapshot: Key ESG Trends in the In Vitro Diagnostics Industry
Figure 36 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 37 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 38 : BD: Revenue Shares, by Country/Region, FY 2023
Figure 39 : BD: Revenue Shares, by Business Unit, FY 2023
Figure 40 : bioMerieux: Revenue Shares, by Country/Region, FY 2023
Figure 41 : bioMerieux: Revenue Shares, by Business Unit, FY 2023
Figure 42 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 43 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 44 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023
Figure 45 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023
Figure 46 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 47 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 48 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 50 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 51 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 52 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
Figure 53 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023
Figure 54 : Sysmex Corp.: Revenue Shares, by Business Unit, FY 2022
Figure 55 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2022
Figure 56 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 57 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023